2019
DOI: 10.1021/acs.joc.9b00148
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Enantiomerically Pure 5-Substituted Piperazine-2-Acetic Acid Esters as Intermediates for Library Production

Abstract: The piperazine heterocycle is housed within a large number of FDA-approved drugs and biological probe compounds. Structurally, however, these compounds are mostly confined to substitutions on the two ring nitrogen atoms, rationalizing the expansion of piperazine chemical diversity through carbon substitutions. On the basis of the concept of systematic chemical diversity, a divergent six-step synthesis was developed in which chiral amino acids were transformed, with high diastereoselectivity, into either cis or… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
12
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 55 publications
0
12
0
Order By: Relevance
“…Our previous studies preparing 2,5-and 2,6-substituted piperazines hinted towards a method of synthesizing indazolefused piperazines and morpholines with a previously unreported merged heterocyclic structure. [17,19] Specifically, in efforts to conduct a base promoted aza-Michael reaction to generate the desired piperazine skeleton, we observed the product resulting from a Smiles rearrangement (Scheme 2B-D). [22,23] To form the desired piperazine products, we circumvented the Smiles rearrangement by developing non-basic conditions leading to efficient aza-Michael cyclization.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Our previous studies preparing 2,5-and 2,6-substituted piperazines hinted towards a method of synthesizing indazolefused piperazines and morpholines with a previously unreported merged heterocyclic structure. [17,19] Specifically, in efforts to conduct a base promoted aza-Michael reaction to generate the desired piperazine skeleton, we observed the product resulting from a Smiles rearrangement (Scheme 2B-D). [22,23] To form the desired piperazine products, we circumvented the Smiles rearrangement by developing non-basic conditions leading to efficient aza-Michael cyclization.…”
Section: Resultsmentioning
confidence: 99%
“…[9][10][11][12][13][14] We have previously reported methods leading to the systematic preparation of diverse enantiomerically pure piperazines and morpholines. [15][16][17][18][19][20][21] These studies led us to consider that a structurally unique collection of compounds could be achieved in the context of merging these stereodiverse ring systems with other biologically valuable heterocycles (Scheme 1). Novel ring systems resulting from the formal union of two simpler heterocyclic scaffolds would expand shape diversity and offer additional vectors for substitution.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Toward achieving this goal, we have previously reported the synthesis of a family of chiral disubstituted piperazine-2-acetic acid esters. Starting from amino acids (natural and unnatural), we constructed 3-, 5- and 6- substituted piperazine-2-acetic acid esters comprising both relative and absolute stereoisomers as single compounds [ 16 , 17 , 18 , 19 , 20 ].…”
Section: Introductionmentioning
confidence: 99%
“…Finally, subjection of 4a to annulation reaction conditions with bromoethyldiphenylsulfonium triflate and sodium hydride 27,28 afforded the anticipated 3-methyl morpholine-2-acetic acid esters as a mixture of diastereomers (5a/6a, cis/trans) in 2:1 ratio (based on crude NMR, Scheme 2). The diastereomeric morpholines were purified by silica gel column chromatography, and the relative stereochemistry of the isolated compounds was determined using NMR techniques, including 1 H, 13 C, and 2D NMR (COSY, HMBC, HSQC, and NOESY; Supporting Information). In keeping with the goal of SCD, we next replicated the reaction sequence, commencing from Bocprotected (R)-alanine 1b, to yield diastereomeric products 5b/ 6b (opposite enantiomers of 5a/6a, Scheme 2).…”
mentioning
confidence: 99%